Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Robert Femia, Ph.D., Named Senior VP of Chemical Medicines and General Chapters at USP

The United States Pharmacopeial Convention announced that Robert Femia, Ph.D., has assumed the role of Senior Vice President, Chemical Medicines and General Chapters. Femia reports to USP’s Chief Science Officer and Executive Vice President, Jaap Venema, and has responsibility for industry standards collaboration as well as chemical medicine monograph and general chapter standards in USP’s compendia, United States Pharmacopeia—National Formulary.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The United States Pharmacopeial Convention (USP) announced that Robert Femia, Ph.D., has assumed the role of Senior Vice President, Chemical Medicines and General Chapters. Femia reports to USP’s Chief Science Officer and Executive Vice President, Jaap Venema, and has responsibility for industry standards collaboration as well as chemical medicine monograph and general chapter standards in USP’s compendia, United States Pharmacopeia—National Formulary (USP–NF).

“USP standards are vital in helping to ensure the quality and safety of chemical medicines that play such a dominant role in healthcare,” said Femia. “I’m proud to be a part of an organization that is so critical to the overall safety net that protects public health.”

Most recently, Dr. Femia was Vice President, Research and Development and Regulatory Affairs (North America), at Sun Pharma/Ranbaxy/Ohm Laboratories (Princeton, NJ), where he provided strategic leadership on product development, regulatory and legal matters, and the development and filings of new products and key site transfers. Prior to joining Sun Pharma, Femia was Vice President, Pharmaceutical Research and Development, at GAT/Nortec (Ramsey, NJ), where he led a new pharmaceutical product division that included drug research and development, regulatory issues and compliance. Earlier in his career, Femia held numerous leadership and technical positions at Par Pharmaceutical, Novartis/Sandoz, Sanofi-Aventis/Hoechst Celanese and Applied Biosystems. He was an Adjunct Professor in the Department of Chemistry at William Paterson University. Dr. Femia received his B.S. in Chemistry from Fairfield University and an M.S. and Ph.D. in Chemistry from Seton Hall University.
One of USP’s current strategic goals is to bring USP–NF’s monographs up-to-date by 2020, an effort in which Femia’s leadership will play a central role. USP’s quality standards for chemically-based small molecule drugs—many of which are generic products in the U.S.—are enforceable under federal law.

“We’re excited to have someone with Bob’s rich experience in pharmaceutical research, quality and industry at USP,” said Dr. Venema. “As the global pharmaceutical landscape continues to grow and transform, USP’s standards will also evolve. Having Bob lead our efforts in chemical medicines and general chapters will be an important part of that transformation.”

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report